Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 69 are a BUY (88.46%), 9 are a HOLD (11.54%).
Analyst Emily Bodnar works with a stock forecast success ratio of 19.53% fulfilled within 56.19 days on average. Previously, Emily Bodnar worked at HCWAINWRIGHT.
Emily Bodnar’s has documented 148 price targets and ratings displayed on 16 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on NVCR, Novocure Ltd at 27-Mar-2024.
Analyst best performing recommendations are on RNAZ (TRANSCODE THERAPEUTICS).
The best stock recommendation documented was for RNAZ (TRANSCODE THERAPEUTICS) at 10/24/2023. The price target of $3 was fulfilled within 84 days with a profit of $2.57 (597.67%) receiving and performance score of 71.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
48
$0.45 (0.95%)
48
7 months 19 days ago
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
56
9 months 2 days ago
0/1 (0%)
$27.35 (95.46%)
Hold
48
$0.45 (0.95%)
68
9 months 8 days ago
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
48
$0.45 (0.95%)
38
9 months 8 days ago
1/2 (50%)
$1.56 (3.36%)
27
Hold
48
$0.45 (0.95%)
71
9 months 8 days ago
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?